Jason Matuszewski
Net worth: 4 M $ as of 30/06/2026
Net worth: 4 M $ as of 30/06/2026
Mr. Jason Matuszewski is a Chairman & Chief Executive Officer at BioStem Technologies, Inc. and a Member at American Association of Tissue Banks.
Mr. Matuszewski was previously employed as a Member by BioFlorida, Inc.
He received his undergraduate degree from Milwaukee School of Engineering.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/09/2025 | 1,170,869 ( 7.17% ) | 4 M $ | 30/06/2026 | |
| 30/09/2025 | 100 ( 33.33% ) | 330 $ | 30/06/2026 |
| Companies | Position | Start |
|---|---|---|
| BIOSTEM TECHNOLOGIES, INC. | Chief Executive Officer | 22/10/2019 |
American Association of Tissue Banks
American Association of Tissue Banks Miscellaneous Commercial ServicesCommercial Services Business association | Corporate Officer/Principal | - |
| Companies | Position | End |
|---|---|---|
BioFlorida, Inc.
BioFlorida, Inc. Miscellaneous Commercial ServicesCommercial Services Provides infrastructure to exchange information and ideas through industry specific programming, education, networking and legislative initiatives. | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
Milwaukee School of Engineering
Milwaukee School of Engineering Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioFlorida, Inc.
BioFlorida, Inc. Miscellaneous Commercial ServicesCommercial Services Provides infrastructure to exchange information and ideas through industry specific programming, education, networking and legislative initiatives. | Commercial Services |
American Association of Tissue Banks
American Association of Tissue Banks Miscellaneous Commercial ServicesCommercial Services Business association | Commercial Services |
BioStem Technologies, Inc.
BioStem Technologies, Inc. BiotechnologyHealth Technology Develops stem cell based medical therapies | Health Technology |
Select your edition
All financial news and data tailored to specific country editions